Publication | Closed Access
Interphylal Product Splicing: The First Total Syntheses of Cephalostatin 1, the North Hemisphere of Ritterazine G, and the Highly Active Hybrid Analogue, Ritterostatin G<sub>N</sub>1<sub>N</sub><sup>1</sup>
110
Citations
39
References
1998
Year
Bioorganic ChemistryMolecular BiologyConvergent Total SynthesesChemical BiologyPharmaceutical ChemistrySplicing VariantMedicinal ChemistryBiosynthesisDiversity Oriented SynthesisCephalostatin 1Natural Product BiosynthesisAnti-cancer AgentNorth HemisphereDerivativesBiochemistryDiversity-oriented SynthesisPharmacologyNatural Product SynthesisProtein BiosynthesisInterphylal Product SplicingNatural SciencesHybrid AnaloguesMedicineDrug Discovery
Convergent total syntheses of the extremely potent cell growth inhibitor cephalostatin 1 and two hybrid analogues, ritterostatins GN1N and GN1S, have been achieved. Ritterostatin GN1N displays sub-nanomolar activity in the 60 cell line human tumor panel of the National Cancer Institute. The North hemisphere of ritterazine G was efficiently constructed from hecogenin acetate in 15% yield over 13 steps. Extension of a key photolysis/Prins sequence to intermediates 19 and 32 proceeded in excellent yield, leading to installation of the Δ14 moiety in the North G and South 1 steroidal subunits. Application of a method for directed unsymmetrical coupling furnished the natural and analogue pyrazines in good yield from the cephalostatin and ritterazine components.
| Year | Citations | |
|---|---|---|
Page 1
Page 1